Essais cliniques en cancérologie à Zurich
163 essais ouverts avec au moins un centre à Zurich, d'après ClinicalTrials.gov, mis à jour le 28 octobre 2026.
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.
Essais ouverts
- A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
NCT05765812Recrutement en coursPhase 1 · Phase 2
- Observational Study Protocol: LIVER-R
NCT06252753Recrutement en cours
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
NCT07020065Recrutement en coursPhase 2
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
NCT07365423Recrutement en coursPhase 2
- A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
NCT05916313Recrutement en coursPhase 1
- OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382Recrutement en cours
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
NCT07574047Recrutement en coursPhase 2
- Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
NCT07593482Recrutement en coursPhase 2
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
NCT07190248Recrutement en coursPhase 3
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729Recrutement en coursPhase 3
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
NCT03970447Recrutement en coursPhase 2 · Phase 3
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
NCT05920356Recrutement en coursPhase 3
- Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT06358573Recrutement en coursPhase 2
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285Recrutement en coursPhase 3
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Recrutement en coursPhase 1 · Phase 2
- The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT05890677Recrutement en cours
- An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT05939414Recrutement en coursPhase 3
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674Recrutement en coursPhase 3
- Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
NCT07840456Pas encore en recrutementPhase 2
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Recrutement en coursPhase 3
- PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT04790253Recrutement en cours
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Recrutement en coursPhase 3
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172Recrutement en cours
- A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Recrutement en coursPhase 1 · Phase 2
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176Recrutement en coursPhase 3
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374Recrutement en coursPhase 3
- DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
NCT06989112Recrutement en coursPhase 3
- Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980Recrutement en coursPhase 2
- European Real-World Registry for Use of the Ion Endoluminal System
NCT06923774Recrutement en cours
- Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
NCT06563362Recrutement en coursPhase 2
- Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814Recrutement en coursPhase 3
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073Recrutement en coursPhase 3
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908Recrutement en coursPhase 1
- Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322Recrutement en coursPhase 3
- Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06697301Recrutement en coursPhase 2 · Phase 3
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819Recrutement en coursPhase 2
- A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187Recrutement en coursPhase 3
- A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT05160584Recrutement en cours
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Recrutement en coursPhase 3
- A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171Recrutement en coursPhase 2
- Visugromab in Cachexia International Trial
NCT07112196Recrutement en coursPhase 2 · Phase 3
- Pharmacoscopy for Patients With Refractory Primary Brain Tumors
NCT06804655Recrutement en coursPhase 2
- Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study
NCT07832123Pas encore en recrutementPhase 2
- Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316Recrutement en coursPhase 3
- Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses
NCT07826897Pas encore en recrutement
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Recrutement en coursPhase 3
- Lung cAncer Robotic Comparative Study
NCT06038227Recrutement en cours
- Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
NCT07026474Recrutement en coursPhase 3
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129Recrutement en coursPhase 2 · Phase 3
- Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438Recrutement en coursPhase 3
- What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?
NCT07544446Recrutement en cours
- Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
NCT07058805Recrutement en coursPhase 2
- Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors
NCT07368153Recrutement en coursPhase 2
- Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035Recrutement en coursPhase 3
- Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Pas encore en recrutementPhase 3
- Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer
NCT07591051Pas encore en recrutement
- Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy
NCT06870799Recrutement en cours
- DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Recrutement en cours
- ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
NCT06801899Recrutement en cours
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868Recrutement en coursPhase 2 · Phase 3
- Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762Recrutement en coursPhase 2 · Phase 3
- Structured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility Study
NCT07723781Pas encore en recrutement
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651Recrutement en coursPhase 3
- AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809Recrutement en coursPhase 3
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
NCT07717437Recrutement en cours
- Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
NCT07617610Recrutement en cours
- FAPI PET Imaging - An Exploratory Study
NCT07705074Pas encore en recrutementPhase 1 · Phase 2
- First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Recrutement en coursPhase 1
- Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions
NCT07687147Recrutement en cours
- Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)
NCT07687264Pas encore en recrutement
- Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT06834152Recrutement en cours
- Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer
NCT07042256Recrutement en cours
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Recrutement en coursPhase 1
- Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial
NCT05508464Recrutement en cours
- Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
NCT06620380Recrutement en coursPhase 2
- Vortioxetine for Newly Diagnosed Glioblastoma
NCT07284628Recrutement en coursPhase 2
- Combination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992Recrutement en coursPhase 2
- SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT02834884Recrutement en cours
- Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149Recrutement en cours
- 177Lu-DOTATATE for Recurrent Meningioma
NCT06326190Recrutement en coursPhase 2
- ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
NCT04732065Recrutement en coursPhase 1
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
NCT05904119Recrutement en coursPhase 3
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
NCT07624760Pas encore en recrutement
- Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Recrutement en coursPhase 3
- A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588Recrutement en coursPhase 3
- Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
NCT06274879Recrutement en coursPhase 2
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
NCT06284317Recrutement en coursPhase 3
- A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection
NCT06291896Recrutement en cours
- Early Pulmonary Dysfunction in Childhood Cancer Patients
NCT05427136Recrutement en cours
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494Recrutement en coursPhase 3
- Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190Recrutement en coursPhase 3
- ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
NCT04916613Recrutement en coursPhase 3
- Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
NCT06852313Recrutement en cours
- Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
NCT05522660Recrutement en coursPhase 3
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05580562Recrutement en coursPhase 3
- First in Human Study of T3P-Y058-739 (T3P)
NCT05120596Recrutement en coursPhase 1 · Phase 2
- Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NCT06114108Recrutement en cours
- Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
NCT07494864Recrutement en cours
- Screening for Brain Metastases
NCT07492121Pas encore en recrutementPhase 2
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Recrutement en coursPhase 1 · Phase 2
- Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
NCT07472972Recrutement en cours
- Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
NCT02280889Recrutement en cours
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297Recrutement en coursPhase 3
- IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314Recrutement en coursPhase 3
- Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
NCT03463954Recrutement en cours
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
NCT07263438Recrutement en coursPhase 2
- Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Bronchoscopy With Subsequent Surgical Resection
NCT07398027Pas encore en recrutement
- A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
NCT05717166Recrutement en coursPhase 3
- Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
NCT06835049Recrutement en coursPhase 2
- Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
NCT07309497Recrutement en cours
- Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
NCT06479070Recrutement en cours
- Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
NCT06680050Recrutement en coursPhase 2
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Recrutement en coursPhase 3
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
NCT05259605Recrutement en cours
- PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057Recrutement en coursPhase 2
- HOPE Against Cancer Recurrence in HCC
NCT06717919Recrutement en coursPhase 4
- VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209Recrutement en cours
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978Recrutement en coursPhase 3
- HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Recrutement en coursPhase 1 · Phase 2
- Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Recrutement en coursPhase 3
- MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289Recrutement en cours
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963Recrutement en cours
- The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
NCT05894070Recrutement en cours
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980Recrutement en cours
- Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
NCT06108375Recrutement en cours
- DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
NCT06615349Recrutement en cours
- Restrictive Use of Dexamethasone in Glioblastoma
NCT04266977Recrutement en cours
- Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
NCT06776172Recrutement en cours
- Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy
NCT06464536Recrutement en cours
- The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Recrutement en cours
- Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients
NCT06665568Pas encore en recrutementPhase précoce 1
- SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
NCT06931847Pas encore en recrutement
- A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485Recrutement en coursPhase 2
- Breath Analysis for the Detection of Invasive Fungal Infections
NCT06537726Recrutement en cours
- The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
NCT06922201Pas encore en recrutement
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276Recrutement en coursPhase 3
- Caregiver Stress and Bereavement
NCT05867706Recrutement en cours
- E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT03818503Recrutement en cours
- Swiss Severe Asthma Register
NCT03984253Recrutement en cours
- Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326Recrutement en cours
- EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
NCT05688241Pas encore en recrutementPhase 1 · Phase 2
- Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study
NCT06489665Recrutement en cours
- PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Recrutement en coursPhase 3
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Recrutement en cours
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
NCT05502380Recrutement en coursPhase 3
- Research Collaboration for a Precision Oncology Program (POP)
NCT06680726Recrutement en cours
- Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer
NCT04289935Recrutement en cours
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT04498767Recrutement en cours
- Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
NCT06550102Recrutement en cours
- Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NCT03222635Recrutement en cours
- Mastocytosis Registry (of Zurich)
NCT06466889Recrutement en cours
- Therapy-Associated Saliva and Taste Change Evaluation (TASTE) in Head & Neck Cancer Patients Undergoing Radiotherapy
NCT06444776Recrutement en cours
- Cerebrovascular Disease: Quality of Life (CODE: QoL)
NCT06443268Recrutement en cours
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907Recrutement en coursPhase 1 · Phase 2
- Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
NCT06417710Recrutement en cours
- Glutamate Inhibitors in Glioblastoma
NCT05664464Recrutement en coursPhase 1 · Phase 2
- Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
NCT06360627Recrutement en cours
- Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
NCT04300257Recrutement en cours
- Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases
NCT06230666Recrutement en cours
- INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042Recrutement en coursPhase 1 · Phase 2
- Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
NCT04443010Recrutement en coursPhase 1 · Phase 2
- Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
NCT04045691Recrutement en cours
- Multicenter Pheochromocytoma and Paraganglioma Evaluation
NCT03344016Recrutement en cours